Janney Montgomery Scott’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.6M Sell
343,226
-30,444
-8% -$2.35M 0.06% 298
2025
Q4
$29.7M Sell
373,670
-19,764
-5% -$1.56M 0.07% 277
2025
Q3
$29.7M Buy
393,434
+78,417
+25% +$5.37M 0.07% 268
2025
Q2
$21.7M Sell
315,017
-81
-0% -$5.31K 0.06% 325
2025
Q1
$21.3M Buy
315,098
+56,156
+22% +$3.36M 0.06% 313
2024
Q4
$11.6M Sell
258,942
-79,297
-23% -$4.45M 0.03% 489
2024
Q3
$21.3M Sell
338,239
-111,292
-25% -$6.49M 0.06% 321
2024
Q2
$26.5M Sell
449,531
-148,317
-25% -$9.28M 0.08% 254
2024
Q1
$47.7M Sell
597,848
-367,404
-38% -$28.1M 0.14% 146
2023
Q4
$76.2M Sell
965,252
-8,608
-0.9% -$613K 0.25% 82
2023
Q3
$68M Buy
973,860
+8,253
+0.9% +$585K 0.25% 80
2023
Q2
$66.8M Buy
965,607
+32,951
+4% +$2.34M 0.23% 90
2023
Q1
$69.3M Sell
932,656
-11,248
-1% -$943K 0.28% 75
2022
Q4
$88M Buy
943,904
+6,896
+0.7% +$665K 0.34% 65
2022
Q3
$89.4M Buy
937,008
+45,027
+5% +$4.46M 0.38% 57
2022
Q2
$83.1M Sell
891,981
-10,319
-1% -$1.01M 0.38% 58
2022
Q1
$91.3M Sell
902,300
-19,006
-2% -$2M 0.39% 53
2021
Q4
$95M Buy
921,306
+16,431
+2% +$1.52M 0.37% 59
2021
Q3
$76.8M Buy
904,875
+23,146
+3% +$1.94M 0.33% 70
2021
Q2
$73.6M Sell
881,729
-13,728
-2% -$1.12M 0.32% 68
2021
Q1
$67.4M Buy
895,457
+25,825
+3% +$1.88M 0.33% 72
2020
Q4
$59.4M Buy
869,632
+30,072
+4% +$1.96M 0.29% 83
2020
Q3
$49M Buy
839,560
+6,240
+0.7% +$388K 0.28% 87
2020
Q2
$54.1M Buy
833,320
+41,200
+5% +$2.59M 0.34% 66
2020
Q1
$47M Sell
792,120
-11,571
-1% -$772K 0.37% 61
2019
Q4
$59.7M Sell
803,691
-48,621
-6% -$3.41M 0.39% 54
2019
Q3
$53.8M Buy
852,312
+15,780
+2% +$935K 0.39% 57
2019
Q2
$45.6M Buy
836,532
+121,174
+17% +$6.53M 0.35% 61
2019
Q1
$38.6M Buy
715,358
+360,215
+101% +$22.2M 0.32% 72
2018
Q4
$23.3M Buy
355,143
+70,501
+25% +$5.26M 0.22% 107
2018
Q3
$22.4M Buy
284,642
+15,586
+6% +$1.11M 0.19% 113
2018
Q2
$17.3M Buy
269,056
+4,071
+2% +$268K 0.17% 134
2018
Q1
$16.5M Buy
264,985
+9,297
+4% +$667K 0.17% 135
2017
Q4
$18.5M Buy
255,688
+36,480
+17% +$2.65M 0.19% 119
2017
Q3
$17.8M Buy
219,208
+25,416
+13% +$2.01M 0.2% 111
2017
Q2
$15.6M Sell
193,792
-16,856
-8% -$1.33M 0.19% 117
2017
Q1
$16.5M Sell
210,648
-23,733
-10% -$1.89M 0.22% 102
2016
Q4
$18.5M Buy
234,381
+719
+0.3% +$58.2K 0.28% 83
2016
Q3
$20.8M Sell
233,662
-215,824
-48% -$20.4M 0.37% 63
2016
Q2
$43M Buy
+449,486
New +$44.8M 0.88% 25
2016
Q1
Sell
-174,000
Closed -$17M 1295
2015
Q4
$17M Buy
174,000
+12,328
+8% +$1.21M 0.44% 52
2015
Q3
$15.6M Buy
161,672
+7,928
+5% +$833K 0.44% 47
2015
Q2
$16.1M Sell
153,744
-2,359
-2% -$241K 0.34% 52
2015
Q1
$16.1M Buy
156,103
+4,814
+3% +$487K 0.3% 54
2014
Q4
$14.6M Buy
151,289
+402
+0.3% +$35.4K 0.29% 56
2014
Q3
$12M Buy
150,887
+9,001
+6% +$710K 0.25% 78
2014
Q2
$10.7M Buy
141,886
+24,127
+20% +$1.82M 0.23% 92
2014
Q1
$8.82M Buy
117,759
+14,062
+14% +$993K 0.21% 101
2013
Q4
$7.42M Buy
103,697
+2,639
+3% +$170K 0.2% 114
2013
Q3
$5.74M Buy
101,058
+71,417
+241% +$4.26M 0.17% 135
2013
Q2
$1.69M Buy
+29,641
New +$1.72M 0.18% 141

Other funds holding CVS

Janney Montgomery Scott's CVS Position: Q1 2026 in Review

Janney Montgomery Scott reduced its CVS Health (CVS) stake by 8.1% in Q1 2026, selling an estimated $2.35M and leaving 343,226 shares worth $24.6M. The position accounts for 0.06% of the portfolio, ranked #298.

Janney Montgomery Scott first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $95M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Janney Montgomery Scott held 343,226 shares of CVS Health worth $24.6M as of Q1 2026.
  • Janney Montgomery Scott sold 30,444 CVS Health shares in Q1 2026, an estimated $2.35M.
  • CVS Health made up 0.06% of Janney Montgomery Scott's portfolio in Q1 2026, its #298 holding.
  • Janney Montgomery Scott first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Janney Montgomery Scott's CVS Health position peaked at $95M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.